Skip to Content
Merck

47601

Fmoc-Ser-OH

≥97.0% (sum of enantiomers, HPLC)

Synonym(s):

Fmoc-L-serine

Sign In to View Organizational & Contract Pricing.

Select a Size

5 G

PLN 453.05

PLN 453.05

List PricePLN 533.00Save 15%

Please contact Customer Service for Availability

Request a Bulk Order

About This Item

Empirical Formula (Hill Notation):
C18H17NO5
CAS Number:
Molecular Weight:
327.33
UNSPSC Code:
12352209
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
4715791

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Fmoc-Ser-OH, ≥97.0% (sum of enantiomers, HPLC)

InChI

1S/C18H17NO5/c20-9-16(17(21)22)19-18(23)24-10-15-13-7-3-1-5-11(13)12-6-2-4-8-14(12)15/h1-8,15-16,20H,9-10H2,(H,19,23)(H,21,22)/t16-/m0/s1

SMILES string

OC[C@H](NC(=O)OCC1c2ccccc2-c3ccccc13)C(O)=O

InChI key

JZTKZVJMSCONAK-INIZCTEOSA-N

assay

≥97.0% (sum of enantiomers, HPLC)

optical activity

[α]20/D −12.5±1°, c = 1% in DMF

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

application(s)

peptide synthesis

functional group

Fmoc

storage temp.

2-8°C

Quality Level

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
475634763447619
assay

≥97.0% (sum of enantiomers, HPLC)

assay

≥98.0%

assay

≥98.0% (HPLC)

assay

≥98.0% (HPLC)

functional group

Fmoc

functional group

Fmoc

functional group

Fmoc

functional group

Fmoc

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

optical activity

[α]20/D −12.5±1°, c = 1% in DMF

optical activity

[α]20/D +8.0±1°, c = 1% in DMF

optical activity

[α]20/D -29.5±1.5°, c = 1% in DMF

optical activity

[α]20/D +25.5±1°, c = 1% in ethyl acetate

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Annabelle Biscans et al.
Nucleic acids research, 47(3), 1082-1096 (2018-12-14)
Small interfering RNA (siRNA)-based therapies are proving to be efficient for treating liver-associated disorders. However, extra-hepatic delivery remains challenging, limiting therapeutic siRNA utility. We synthesized a panel of fifteen lipid-conjugated siRNAs and systematically evaluated the impact of conjugate on siRNA
Frans J Walther et al.
PloS one, 5(1), e8672-e8672 (2010-01-20)
Surfactant protein B (SP-B; 79 residues) belongs to the saposin protein superfamily, and plays functional roles in lung surfactant. The disulfide cross-linked, N- and C-terminal domains of SP-B have been theoretically predicted to fold as charged, amphipathic helices, suggesting their
Jingwen Song et al.
Small (Weinheim an der Bergstrasse, Germany), 16(8), e1907309-e1907309 (2020-01-30)
There is a real need for new antibiotics against self-evolving bacteria. One option is to use biofriendly broad-spectrum and mechanically tunable antimicrobial hydrogels that can combat multidrug-resistant microbes. Whilst appealing, there are currently limited options. Herein, broad-spectrum antimicrobial biometallohydrogels based
Peiming Chen et al.
Journal of controlled release : official journal of the Controlled Release Society, 194, 341-349 (2014-09-16)
Macrophages are involved in a number of diseases, such as HIV infection/AIDS, tuberculosis, tumor development and atherosclerosis. Macrophages possess several cell surface receptors (e.g., the mannose receptor, MR) that may serve as drug delivery cellular portals for nanocarriers (NCs). In

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service